Skip to main content
Year archive

NeopharmCO.,LTD. — 2025 filings

All 22 regulatory filings released by NeopharmCO.,LTD. (092730) in 2025, sourced directly from the official regulator.

22 Filings
2025 Period
2025 filings (22)
Filing Released Lang
기업설명회(IR)개최
Regulatory Filings
2025-11-11 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Regulatory Filings
2025-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-28 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-10-28 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-09-17 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-08-27 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2025
2025-08-01 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-05-28 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2025
2025-05-09 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2025-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-03-26 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-17 Korean
사업보고서 (2024.12)
Annual Report FY 2024
2025-03-17 Korean
주주총회소집공고
AGM Information
2025-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2025-03-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2025-02-04 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2024
2025-02-04 Korean